# PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

> **NCT07210320** · PHASE1 · COMPLETED · sponsor: **Insignis Therapeutics, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Food Allergy
- Anaphylaxis
- Food Hypersensitivity
- Food Allergy Peanut

## Interventions

- **DRUG:** Epinephrine Auto-Injector 0.3 mg/0.3 mL
- **DRUG:** Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle
- **DRUG:** IN-001 9.06 mg Sublingual Spray
- **DRUG:** IN-001 13.59 mg Sublingual Spray

## Key facts

- **NCT ID:** NCT07210320
- **Lead sponsor:** Insignis Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-24
- **Primary completion:** 2026-04-12
- **Final completion:** 2026-04-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07210320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07210320, "PK/PD Study of IN-001 Sublingual Spray in Healthy Adults". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07210320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*